David Bailey
Stock Analyst at Morgan Stanley
(3.48)
# 2,283
Out of 4,504 analysts
198
Total ratings
40.6%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RMD ResMed Inc. | Maintained: Hold | n/a | $30.03 | - | 28 | Jul 8, 2026 | |
| RMD ResMed | Maintained: Hold | $230 | $203.87 | +12.82% | 16 | Jul 7, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $238.77 → $174.00 | $121.27 | +43.48% | 30 | Jun 29, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $2.90 → $3.50 | $2.07 | +69.08% | 2 | Jun 3, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Sell | $32.90 | $42.28 | -22.19% | 35 | Jun 1, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $40.00 | $40.32 | -0.79% | 10 | May 25, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $22.40 | $16.27 | +37.68% | 14 | May 24, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $34.40 → $29.30 | $31.36 | -6.57% | 14 | May 6, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Downgraded: Sell | $25.20 → $20.30 | $21.26 | -4.49% | 18 | May 6, 2026 | |
| ASX: COH Cochlear Limited | Upgraded: Hold | $194.00 → $119.00 | $121.62 | -2.15% | 14 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $127.50 → $152.50 | $196.28 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.50 → $1.35 | $0.385 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $3.55 | $6.32 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.80 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.36 | $2.87 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $1.02 | n/a | 1 | Jan 21, 2021 |
ResMed Inc.
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $30.03
Upside: -
ResMed
Jul 7, 2026
Maintained: Hold
Price Target: $230
Current: $203.87
Upside: +12.82%
CSL Limited
Jun 29, 2026
Maintained: Buy
Price Target: $238.77 → $174.00
Current: $121.27
Upside: +43.48%
Integral Diagnostics Limited
Jun 3, 2026
Maintained: Buy
Price Target: $2.90 → $3.50
Current: $2.07
Upside: +69.08%
Ramsay Health Care Limited
Jun 1, 2026
Maintained: Sell
Price Target: $32.90
Current: $42.28
Upside: -22.19%
Fisher & Paykel Healthcare Corporation Limited
May 25, 2026
Maintained: Buy
Price Target: $40.00
Current: $40.32
Upside: -0.79%
Telix Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $22.40
Current: $16.27
Upside: +37.68%
Ansell Limited
May 6, 2026
Maintained: Hold
Price Target: $34.40 → $29.30
Current: $31.36
Upside: -6.57%
Sonic Healthcare Limited
May 6, 2026
Downgraded: Sell
Price Target: $25.20 → $20.30
Current: $21.26
Upside: -4.49%
Cochlear Limited
Apr 23, 2026
Upgraded: Hold
Price Target: $194.00 → $119.00
Current: $121.62
Upside: -2.15%
Aug 15, 2024
Maintained: Buy
Price Target: $127.50 → $152.50
Current: $196.28
Upside: n/a
Feb 28, 2024
Maintained: Hold
Price Target: $1.50 → $1.35
Current: $0.385
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $3.05 → $3.55
Current: $6.32
Upside: n/a
Aug 24, 2021
Maintained: Hold
Price Target: n/a
Current: $14.80
Upside: n/a
Jan 21, 2021
Maintained: Hold
Price Target: $0.36
Current: $2.87
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $1.02
Upside: n/a